ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2025, Vol. 34 ›› Issue (4): 309-314.DOI: 10.3969/j.issn.1006-298X.2025.04.002

• 论著 • 上一篇    下一篇

金属蛋白酶组织抑制剂 2 联合胰岛素样生长因子结合蛋白 7 对急性胰腺炎患者急性肾损伤的预测价值

  

  • 出版日期:2025-08-28 发布日期:2025-08-28

The predictive value of renal injury biomarkers TIMP-2 combined with IGFBP-7 for acute kidney injury in patients with acute pancreatitis

  • Online:2025-08-28 Published:2025-08-28

摘要: 目的:研究肾损伤标志物金属蛋白酶组织抑制剂 2(TIMP-2)联合胰岛素样生长因子结合蛋白 7(IGFBP-7)对急性胰腺炎患者入院后发生急性肾损伤(AKI)的预测价值及最佳阈值。
方法:这是一项多中心临床研究的二次分析,选择 2021 年 4 月至 2022 年 4 月全国 11 家急重症中心收治的急性胰腺炎患者临床资料。入院后收集患者血清标本,测量血清中生物标志物 [TIMP-2][IGFBP-7] 水平。使用受试者工作特征曲线下面积(AUC)评估该生物标志物对 AKI 的预测价值,并评估本研究中的最佳阈值。多因素 Logistic 回归模型评估发生 AKI 的独立危险因素。以阈值分组,比较高低标志物组人群间临床结局的差异。
结果:本研究共纳入 84 例急性胰腺炎患者,其中 19 例患者发生 AKI。[TIMP-2][IGFBP-7] 预测 AKI 时 AUC 为 0.83(最佳阈值为 2.46),敏感度为 88.9%,特异度为 66.1%。多因素 Logistic 回归显示,急性生理学及慢性健康状况评估系统 Ⅱ(APACHE Ⅱ)评分和 [TIMP-2][IGFBP-7] 水平都是 AKI 发生的独立危险因素。高标志物组(≥2.46)入院第 3 天发生器官功能衰竭的比例更高(P=0.019),且重症监护住院时间更长(P=0.030)。
结论:肾损伤标志物 [TIMP-2][IGFBP-7] 能早期预测急性胰腺炎入院后 AKI 的发生。高于阈值人群与重症监护病房住院时长增长和器官衰竭发生率增高相关。

关键词: font-family:Inter, -apple-system, BlinkMacSystemFont, ", font-size:16px, background-color:#F9FAFB, ">急性胰腺炎, 急性肾损伤, 标志物, 预测价值

Abstract: Objective: Early detection of acute kidney injury in acute pancreatitis is of great significance for treatment and prognosis. The objective of this study was to investigate the predictive value and optimal cut-off value of tissue inhibitor of metalloproteinases-2 (TIMP-2)insulin-like growth factor-binding protein 7 (IGFBP-7) for the occurrence of acute kidney injury (AKI) after admission in patients with acute pancreatitis (AP).
Methodology: The study was a posthoc analysis of a multicenter clinical trial. The clinical data of AP patients who met the eligibility criteria and were admitted to 11 emergency and critical care centers across the country from April 2021 to April 2022 were selected. After admission, blood samples of the patients were collected to measure the levels of [TIMP-2][IGFBP-7]. The area under curve (AUC) was used to evaluate the predictive value of this biomarker for AKI, and the optimal cut-off value in this study was evaluated. Multivariate logistic regression model was used to evaluate the independent risk factors for AKI. The differences in clinical outcomes between the high and low marker groups were compared, which were distinguished by the optimal cut-off value.
Results: A total of 84 patients with AP were included in this study, among whom 19 patients (22.6%) developed AKI. The AUC predicted by [TIMP-2][IGFBP-7] for AKI was 0.83 (the optimal cut-off value was 2.46), the sensitivity was 88.9%, and the specificity was 66.1%. Multivariate logistic regression showed that the Acute Physiology and Chronic Health Evaluation System Ⅱ (APACHE Ⅱ) score and the levels of [TIMP-2][IGFBP-7] were associated with AKI. The proportion of organ failure occurring on the third day of admission was higher in the high-marker group (≥2.46) (P=0.019) and the length of intensive care unit (ICU) stay was longer (P=0.030).
Conclusion: Renal injury biomarker ([TIMP-2]*[IGFBP-7]) can predict the occurrence of AKI after admission in AP patients. The population above the cut-off value was associated with an increased length of stay in the ICU and a higher incidence of organ failure. In the future, this biomarker may help to identify high-risk patients with AKI in AP at an early stage, prompt clinical attention, and enable early intervention, ultimately improving prognosis.

Key words: font-family:Inter, -apple-system, BlinkMacSystemFont, ", font-size:16px, background-color:#F9FAFB, ">acute pancreatitis, acute kidney injury, biomarker, predictive value